These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24473850)

  • 41. Intervention to improve adherence to lipid-lowering medication and lipid-levels in patients with an increased cardiovascular risk.
    Nieuwkerk PT; Nierman MC; Vissers MN; Locadia M; Greggers-Peusch P; Knape LP; Kastelein JJ; Sprangers MA; de Haes HC; Stroes ES
    Am J Cardiol; 2012 Sep; 110(5):666-72. PubMed ID: 22621795
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low-dose aspirin for primary prevention of cardiovascular disease.
    Bredie SJ; Wollersheim H; Verheugt FW; Thien T
    Semin Vasc Med; 2003 May; 3(2):177-84. PubMed ID: 15199480
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness of rosuvastatin compared to other statins for the prevention of cardiovascular events-a cohort study in 395 039 patients from clinical practice.
    Motsko SP; Russmann S; Ming EE; Singh VP; Vendiola RM; Jones JK
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1214-22. PubMed ID: 19780020
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Statin therapy--for whom?].
    Kahri J; Syvänne M
    Duodecim; 2012; 128(8):811-8. PubMed ID: 22616372
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Statins and cerebrovascular disease: new perspectives in stroke prevention].
    Castilla-Guerra L; Fernández-Moreno MC; López-Chozas JM; Jiménez-Hernández MD
    Rev Neurol; 2007 Jan 16-31; 44(2):95-100. PubMed ID: 17236149
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Statins in the management of dyslipidemias].
    Scheen AJ
    Rev Prat; 2011 Oct; 61(8):1120-6. PubMed ID: 22135981
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The need for increased utilization of statins after occlusive stroke.
    Hebert PR; Evans D; Schneider WR; Rodriquez-Paz E; Hennekens CH
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):364-7. PubMed ID: 21193682
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review.
    Fasano S; Margiotta DP; Navarini L; Pierro L; Pantano I; Riccardi A; Afeltra A; Valentini G
    Lupus; 2017 Dec; 26(14):1463-1472. PubMed ID: 28786768
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aspirin therapy in primary cardiovascular disease prevention: a position paper of the European Society of Cardiology working group on thrombosis.
    Halvorsen S; Andreotti F; ten Berg JM; Cattaneo M; Coccheri S; Marchioli R; Morais J; Verheugt FW; De Caterina R
    J Am Coll Cardiol; 2014 Jul; 64(3):319-27. PubMed ID: 25034070
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Acetylsalicylic acid in the prevention and treatment of cardiovascular diseases].
    Łabuz-Roszak B; Horyniecki M; Łącka-Gaździk B
    Wiad Lek; 2018; 71(8):1608-1614. PubMed ID: 30684348
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systematic Review of the Effect of Adherence to Statin Treatment on Critical Cardiovascular Events and Mortality in Primary Prevention.
    Martin-Ruiz E; Olry-de-Labry-Lima A; Ocaña-Riola R; Epstein D
    J Cardiovasc Pharmacol Ther; 2018 May; 23(3):200-215. PubMed ID: 29343082
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of aspirin, statins, colchicine, and IL-1 inhibitors in prevention of cardiovascular events: a systematic integrative review.
    Arboleda V; Hackworth A; Bonnice S; Gonzalez V; Cabrera D; Colletti C; Baxter C; Aleman Oliva C; Kabir S; Huang J; Khan A; Filoramo S; Ecoff S; Demory Beckler M; Kesselman MM
    J Osteopath Med; 2024 Mar; 124(3):97-106. PubMed ID: 37877246
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aspirin in Older Adults: Need for Wider Utilization in Secondary Prevention and Individual Clinical Judgments in Primary Prevention.
    Sehgal M; Wood SK; Ouslander JG; Hennekens CH
    J Cardiovasc Pharmacol Ther; 2017 Nov; 22(6):511-513. PubMed ID: 28279072
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Statins in primary prevention of cardiovascular disease].
    Adham S; Miranda S; Doucet J; Lévesque H; Benhamou Y
    Rev Med Interne; 2018 Jan; 39(1):42-49. PubMed ID: 28866432
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The dose of aspirin for the prevention of cardiovascular and cerebrovascular events.
    Fisher M; Knappertz V
    Curr Med Res Opin; 2006 Jul; 22(7):1239-48. PubMed ID: 16892516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combination therapy to prevent cardiovascular disease: slow progress.
    Smith R; McCready T; Yusuf S
    JAMA; 2013 Apr; 309(15):1595-6. PubMed ID: 23529576
    [No Abstract]   [Full Text] [Related]  

  • 57. Prescription of Aspirin and Statins in Primary Prevention.
    Hennekens CH; Schuttenberg N; Pfeffer MA
    Prim Care; 2019 Mar; 46(1):13-25. PubMed ID: 30704653
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Acetylsalicylic acid for the prevention of primary myocardial infarction and ischemic stroke].
    Samorodskaya IV; Bolotova EV; Boytsov SA
    Ter Arkh; 2015; 87(9):91-96. PubMed ID: 26591559
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aspirin for the prevention of vascular death in women.
    McAnally LE; Corn CR; Hamilton SF
    Ann Pharmacother; 1992 Dec; 26(12):1530-4. PubMed ID: 1482811
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Aspirin in primary prevention of cardiovascular and cerebrovascular diseases].
    Gassanov N; Eicke M; Er F
    Dtsch Med Wochenschr; 2021 Oct; 146(20):1353-1359. PubMed ID: 34644796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.